Health Care: Drugs

Theravance Inc (THRX: NASDAQ)

$27.81 n/a | n/a%
07/21/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 4.76M 135.76M 24.51M 24.22M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 4.76M 135.76M 24.51M 24.22M
Selling, General, and Administrative Expenses 48.44M 30.86M 30.68M 27.48M
Research & Development 125.18M 117.90M 103.57M 75.07M
Operating Income before D & A (EBITDA) -168.86M -13.00M -109.74M -78.32M
Depreciation & Amortization 8.20M 7.33M 7.58M 6.34M
Interest Income 778.00K 460.00K 415.00K 505.00K
Other Income - Net 6.73M 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -169.56M -19.86M -116.90M -84.15M
Interest Expense 9.35M 6.00M 6.02M 6.04M
Pre-Tax Income -178.90M -25.87M -122.93M -90.20M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -170.70M -18.54M -115.34M -83.86M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -170.70M -18.54M -115.34M -83.86M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -170.70M -18.54M -115.34M -83.86M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-170.70M -18.54M -115.34M -83.86M
Preferred Dividends
Net Income Available To Common -170.70M -18.54M -115.34M -83.86M
Basic EPS from Continuing Ops. -1.67 -0.20 -1.41 -1.16
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.67 -0.20 -1.41 -1.16
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.67 -0.20 -1.41 -1.16
Basic Normalized Net Income/Share -1.67 -0.20 -1.41 -1.16
EPS fr Continuing Ops. -1.67 -0.20 -1.41 -1.16
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.67 -0.20 -1.41 -1.16
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.67 -0.20 -1.41 -1.16
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.67 -0.20 -1.41 -1.16
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with THRX

Latest THRX Headlines from TheStreet

More Financial News for THRX

Press Releases for THRX

See All Press Releases

Partner Headlines for THRX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter